Long-term Follow-up of Childhood Cancer Survivors in the Rhône-Alpes and Auvergne Regions of France
Results will help identify long-term complications, respond to patients' expectations, and
evaluate the feasibility of conducting such a follow-up in all patients. They should guide
the choice of the most appropriate tools for care, help assess needs in terms of
collaboration with adult care staff, and identify potential partners.
Observational
Observational Model: Cohort, Time Perspective: Prospective
Medical complications (post cancer treatment)
The investigators note the medical complications from the end of their cancer treatment to the inclusion visit. Theses complications depend on the type of treatment received.
15 years after the end of the cancer treatment
Yes
Claire BERGER, MD
Principal Investigator
CHU de Saint-Etienne
France: Afssaps - Agence française de sécurité sanitaire des produits de santé (Saint-Denis)
1008102
NCT01531478
May 2011
December 2013
Name | Location |
---|